Literature DB >> 20073132

5th Annual Monoclonal Antibodies Conference: March 24-25, 2009, London, UK.

Mari Herigstad, Lisa Urquhart.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20073132      PMCID： PMC2726607          DOI： 10.4161/mabs.1.4.8956

Source DB:  PubMed          Journal:  MAbs        ISSN： 1942-0862            Impact factor:   5.857


× No keyword cloud information.
  32 in total

Review 1.  New challenges to medicare beneficiary access to mAbs.

Authors:  Joshua Cohen; Andrew Wilson
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

2.  Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Authors:  T Yokota; D E Milenic; M Whitlow; J Schlom
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

3.  Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.

Authors:  Y Chen; C Wiesmann; G Fuh; B Li; H W Christinger; P McKay; A M de Vos; H B Lowman
Journal:  J Mol Biol       Date:  1999-11-05       Impact factor: 5.469

Review 4.  Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

Authors:  R K Jain
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

5.  Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Authors:  L G Presta; H Chen; S J O'Connor; V Chisholm; Y G Meng; L Krummen; M Winkler; N Ferrara
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

6.  A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies.

Authors:  J M Davis; J E Pennington; A M Kubler; J F Conscience
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

7.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Authors:  A Abuchowski; J R McCoy; N C Palczuk; T van Es; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

8.  Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

Authors:  Magdalena G Krzystolik; Mehran A Afshari; Anthony P Adamis; Jacques Gaudreault; Evangelos S Gragoudas; Norman A Michaud; Wenjun Li; Edward Connolly; Charles A O'Neill; Joan W Miller
Journal:  Arch Ophthalmol       Date:  2002-03

Review 9.  PEGylated antibodies and antibody fragments for improved therapy: a review.

Authors:  Andrew P Chapman
Journal:  Adv Drug Deliv Rev       Date:  2002-06-17       Impact factor: 15.470

Review 10.  Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen.

Authors:  David M Nanus; Matthew I Milowsky; Lale Kostakoglu; Peter M Smith-Jones; Shankar Vallabahajosula; Stanley J Goldsmith; Neil H Bander
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.